Literature DB >> 12200149

Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex.

Hong Seok Choi1, Je Ho Lee, Jong Gu Park, Young Ik Lee.   

Abstract

We determined the molecular mechanisms by which trichostatin A (TSA) induced insulin-like growth factor-binding protein 3 (IGFBP-3) gene expression in Hep3B cells, a p53-mutant human hepatocellular carcinoma (HCC) cell line. TSA induced the expressions of the IGFBP-3 mRNA and protein and the activation of its promoter. Using IGFBP-3 promoter deletion constructs, the TSA-responsive element was mapped to a region between -115 and -30, relative to the transcription start site. Promoter mutation analysis confirmed that the TSA-responsive element coincides with the Sp1/GC-rich region on the IGFBP-3 promoter. This transcriptional activation appears to be mediated by both the Sp1 and Sp3 transcription factors and, in particular, by the phosphorylation of Sp1, because treatment of Hep3B cells and Schneider (SL2) cells with TSA significantly activated phosphorylation of Sp1 in a dose-dependent manner. Consistent with the transcriptional activation of the IGFBP-3 promoter by TSA, TSA treatment led to the release of HDAC1 and Sp3 from the Sp1 transcriptional factor complex, indicating the involvement of multiprotein complexes containing Sp1, Sp3, p300, and HDAC-1 in IGFBP-3 activation by TSA. Taken together, these results show that Sp1 phosphorylation and the modulation of the Sp1/Sp3/HDAC1 multiprotein complex play a pivotal role in the transcriptional activation of the IGFBP-3 promoter through the Sp1/GC-rich site by TSA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12200149     DOI: 10.1016/s0006-291x(02)02001-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Small-molecule-based identification of dynamic assembly of E2F-pocket protein-histone deacetylase complex for telomerase regulation in human cells.

Authors:  Jaejoon Won; Seungwoo Chang; Sangtaek Oh; Tae Kook Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

2.  Role for transcription factor TFII-I in the suppression of SSeCKS/Gravin/Akap12 transcription by Src.

Authors:  Yahao Bu; Lingqiu Gao; Irwin H Gelman
Journal:  Int J Cancer       Date:  2011-04-15       Impact factor: 7.396

3.  Phosphatidylinositol 3-kinase/protein kinase Czeta-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression [corrected] of transcription of the luteinizing hormone receptor gene.

Authors:  Ying Zhang; Mingjuan Liao; Maria L Dufau
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

4.  Mobilization-competent Lentiviral Vector-mediated Sustained Transcriptional Modulation of HIV-1 Expression.

Authors:  Anne-Marie W Turner; Justin De La Cruz; Kevin V Morris
Journal:  Mol Ther       Date:  2008-12-09       Impact factor: 11.454

5.  Histone deacetylase inhibitors enhance the apoptotic activity of insulin-like growth factor binding protein-3 by blocking PKC-induced IGFBP-3 degradation.

Authors:  Seung Hyun Oh; Young Mi Whang; Hye-Young Min; Seung Ho Han; Ju-Hee Kang; Ki-Hoon Song; Bonnie S Glisson; Yeul Hong Kim; Ho-Young Lee
Journal:  Int J Cancer       Date:  2012-03-28       Impact factor: 7.396

6.  Involvement of insulin-like growth factor-binding protein-3 in the effects of histone deacetylase inhibitor MS-275 in hepatoma cells.

Authors:  Wen Hui Lin; Janet L Martin; Deborah J Marsh; Michelle M Jack; Robert C Baxter
Journal:  J Biol Chem       Date:  2011-07-07       Impact factor: 5.157

7.  Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancer.

Authors:  Missak Haigentz; Mimi Kim; Catherine Sarta; Juan Lin; Roger S Keresztes; Bruce Culliney; Anu G Gaba; Richard V Smith; Geoffrey I Shapiro; Lucian R Chirieac; John M Mariadason; Thomas J Belbin; John M Greally; John J Wright; Robert I Haddad
Journal:  Oral Oncol       Date:  2012-06-28       Impact factor: 5.337

8.  Autoregulation of mouse histone deacetylase 1 expression.

Authors:  Bernd Schuettengruber; Elisabeth Simboeck; Harald Khier; Christian Seiser
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

9.  Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency.

Authors:  Fang Lu; Jing Zhou; Andreas Wiedmer; Kevin Madden; Yan Yuan; Paul M Lieberman
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  Sp1 acetylation is associated with loss of DNA binding at promoters associated with cell cycle arrest and cell death in a colon cell line.

Authors:  Jennifer S Waby; Haridasan Chirakkal; ChenWei Yu; Gareth J Griffiths; Roderick S P Benson; Colin D Bingle; Bernard M Corfe
Journal:  Mol Cancer       Date:  2010-10-15       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.